News on haematological malignancies
New technology helps in hunt for new cancer drug combinations
A revolutionary new technology has been applied to reveal the inner workings of individual cancer…
Browsing: Haematology
Study reveals properties of cells fated to relapse in acute lymphoblastic leukaemia
Scientists at St. Jude Children’s Research Hospital and Princess Margaret Cancer Centre in Toronto, Canada,…
FDA approves new therapy for patients with previously treated multiple myeloma
Today, the U.S. Food and Drug Administration (FDA) approved isatuximab-irfc, in combination with pomalidomide and…
Old weapon, new target: Dasatinib against angioimmunoblastic T-cell lymphoma
Researchers from the University of Tsukuba, Japan, show that angioimmunoblastic T-cell lymphoma (AITL) is dependent…
DNA topological problems may cause lymphoma
Researchers from the Spanish National Cancer Research Centre (CNIO), Madrid, and the Andalusian Molecular Biology…
New front opened in fight against common cancer driver
Walter and Eliza Hall Institute researchers have revealed a new vulnerability in lymphomas that are…
New study finds cellular immunotherapy treatment associated with improved quality of life
Adult lymphoma patients whose disease was effectively treated with chimeric antigen receptor T-cell (CAR-T) therapy…
New CAR-T target yields promising results for multiple myeloma
Too many patients with cancers like multiple myeloma relapse after treatment. This grim reality motivated…
CRISPR-edited immune cells can survive and thrive after infusion into cancer patients
Genetically-edited immune cells can persist, thrive, and function months after a cancer patient receives them,…
CD19 CAR NK-cell therapy achieves 73% response rate in patients with leukaemia and lymphoma
According to results from a Phase I/IIa trial at The University of Texas MD Anderson…